Skip to content

Innoviva, Inc. INVA Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Merck & Co. logo
Merck & Co.MRK
-$460.25M+20.9%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-$3.83M+21.5%
Organon logo
OrganonOGN
$95M+144%
LQD
Liquidia CorporationLQDA
$14.53M+402%
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
-$20.98M-45.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$10.79M+8.7%

Other financials

Income statement

See full
Revenue$98.0M+10.6%
Gross profit$75.8M+3.4%
Operating income$38.2M-7.9%
Net income$186.6M+501%
EPS (diluted)$2.22+400%

Balance sheet

See full
Cash & equivalents$603.1M+89.0%
Total debt$269.4M-40.3%
Total equity$1.3B
Total assets$1.8B+46.4%

Cash flow

See full
Operating cash flow$35.3M-27.4%
CapEx$492.0K
Free cash flow$34.8M-28.4%

Valuation

See full
Market cap$1.74B+51.8%
Enterprise value$1.41B+9.7%
P/E3.5×
P/S4.2×+1.0×

Profitability

See full
Gross margin73.7%-9.9pp
Operating margin38.1%-11.2pp
Net margin119.9%+107pp
FCF margin54.1%+5.3pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio21.1×+18.7×

Where this comes from

Reported directly by Innoviva, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Innoviva, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innoviva, Inc.'s change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Innoviva, Inc.'s change in accrued liabilities?
Innoviva, Inc. (INVA) reported change in accrued liabilities of -$9.8M in Q1 2026.
How has Innoviva, Inc.'s change in accrued liabilities changed year-over-year?
Innoviva, Inc.'s change in accrued liabilities decreased by 103.7% year-over-year, from -$4.81M to -$9.8M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.